Abbott shuts down its Michigan baby formula plant again after severe storms flood parts of building 


Abbott shuts down its Michigan baby formula plant AGAIN after severe storms flooded parts of the building

  • The Abbott Laboratories plant in Sturgis, Michigan has been at the center of the nation’s baby formula shortage crisis
  • It restarted on June 4 after being closed since February due to contamination 
  • Now, severe storms that swept through on Monday have closed the factory again
  • Abbott says it needs to assess damage and re-sanitize the factory
  • The shutdown is likely to delay baby formula production for a few weeks
  • The company offered no time frame for when production will resume

Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted after being closed for several months.

The facility is closely tied to the recent baby formula shortage.

Production for its EleCare specialty formula has been suspended, but there is enough supply to meet demand until production is restarted, the company said. 

The company put a priority on ramping up production of the specialty formula for infants with severe food allergies and digestive problems who have few other options for nutrition.

Abbott says it needs to assess damage and re-sanitize the factory after severe thunderstorms and heavy rains swept through southwestern Michigan late Monday. The company didn´t indicate how much damage the factory sustained.

Abbott had restarted the Sturgis, Michigan, factory on June 4 after it had been closed since February due to contamination.

Abbott had restarted the Sturgis, Michigan, factory on June 4 after it had been closed since February due to contamination

The factory was closed after the Food and Drug Administration began investigating four bacterial infections among infants who consumed powdered formula from the plant. Two of the babies died. The company continues to state that its products have not been directly linked to the infections, which involved different bacterial strains.

FDA inspectors eventually uncovered a host of violations at the plant, including bacterial contamination, a leaky roof and lax safety protocols.

Abbott recalled several leading brands of formula in February, including Similac. That squeezed squeezed supplies that had already been strained by supply chain disruptions and stockpiling during COVID-19 shutdowns.

The company offered no time frame in its statement for when production will resume.



Source link

Leave a Reply

Your email address will not be published.